FDA Warns of Increased Heart-Related Issues From Pfizer’s Arthritis Drug Xeljanz Post author By Post date December 3, 2021 The U.S. Food and Drug Administration Read MoreShare this:TwitterFacebookLike Loading... Related Tags analysis, business, business news, economy, economy news, finance, market analysis, market research, markets, news, world news ← Canadian Dollar Hits a 10-Week Low on Rising Risk Aversion → Prospect Park Capital Completes Acquisition of Tutors on Demand